Aridis Pharmaceuticals, Inc.
ARDS
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.00K | 19.00K | 1.32M | 4.88M | 1.89M |
| Total Receivables | 517.00K | 300.00K | 100.00K | 1.24M | 248.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.56M | 3.57M | 3.16M | 3.34M | 3.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.99M | 2.17M | 2.73M |
| Total Current Assets | 4.11M | 3.88M | 6.57M | 11.63M | 8.64M |
|
|
|||||
| Total Current Assets | 4.11M | 3.88M | 6.57M | 11.63M | 8.64M |
| Net Property, Plant & Equipment | 1.58M | 1.76M | 1.95M | 2.15M | 2.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 13.00K | 14.00K | 15.00K | 17.00K | 18.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 827.00K | 827.00K | 906.00K | 905.00K | 961.00K |
| Total Assets | 6.53M | 6.48M | 9.43M | 14.70M | 12.12M |
|
|
|||||
| Total Accounts Payable | 5.41M | 6.24M | 4.12M | 2.31M | 4.23M |
| Total Accrued Expenses | 7.69M | 8.46M | 9.41M | 9.56M | 8.49M |
| Short-term Debt | -- | -- | 208.00K | 519.00K | 831.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.99M | 5.29M | 2.59M | 4.32M | 8.32M |
| Total Finance Division Other Current Liabilities | 395.00K | 403.00K | 19.11M | 20.19M | 20.40M |
| Total Other Current Liabilities | 395.00K | 403.00K | 19.11M | 20.19M | 20.40M |
| Total Current Liabilities | 17.48M | 20.39M | 35.43M | 36.90M | 42.28M |
|
|
|||||
| Total Current Liabilities | 17.48M | 20.39M | 35.43M | 36.90M | 42.28M |
| Long-Term Debt | -- | -- | -- | -- | 3.50M |
| Short-term Debt | -- | -- | 208.00K | 519.00K | 831.00K |
| Capital Leases | 854.00K | 1.00M | 1.15M | 1.29M | 1.43M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 737.00K | 737.00K | 737.00K |
| Total Liabilities | 18.34M | 21.40M | 37.32M | 38.93M | 47.94M |
|
|
|||||
| Common Stock & APIC | 170.83M | 168.90M | 168.69M | 166.38M | 153.46M |
| Retained Earnings | -190.42M | -190.34M | -202.48M | -195.67M | -189.28M |
| Treasury Stock & Other | 7.79M | 6.53M | 5.91M | 5.05M | -- |
| Total Common Equity | -11.80M | -14.91M | -27.88M | -24.23M | -35.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.80M | -14.91M | -27.88M | -24.23M | -35.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.80M | -14.91M | -27.88M | -24.23M | -35.82M |
|
|
|||||